MedPath

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease

Phase 2
Withdrawn
Conditions
Cushing's Disease
Interventions
First Posted Date
2020-04-09
Last Posted Date
2025-04-15
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
22
Registration Number
NCT04339751
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

The Beneficial Effects of Naps on Motor Learning

Recruiting
Conditions
Stroke
Interventions
Device: MRI system
Device: MEG system
First Posted Date
2020-03-18
Last Posted Date
2025-05-16
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
199
Registration Number
NCT04312126
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Study of Direct Brain Recording and Stimulation for Memory Enhancement

Conditions
Epilepsy
First Posted Date
2019-09-19
Last Posted Date
2025-03-30
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
200
Registration Number
NCT04095026
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2019-07-19
Last Posted Date
2024-12-27
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
8
Registration Number
NCT04025554
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Modulating the Hippocampal and Striatal Memory Networks With rTMS

Not Applicable
Completed
Conditions
Normal Behavioral Patterns
Interventions
Other: RTMS
First Posted Date
2019-06-21
Last Posted Date
2022-07-06
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
13
Registration Number
NCT03994120
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)

Terminated
Conditions
Myotonic Dystrophy Type-1
Myotonic Dystrophy Type-2
First Posted Date
2019-03-08
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
4
Registration Number
NCT03867435
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Exploring the Relationship Between Brain Asymmetry and Attention

Not Applicable
Completed
Conditions
Normal Physiology
Interventions
Device: TMS EEG
Device: TMS fMRI
First Posted Date
2018-12-28
Last Posted Date
2022-10-26
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
45
Registration Number
NCT03789201
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Large-Scale Online Studies of Early Motor Skill Learning

Completed
Conditions
Healthy
First Posted Date
2018-11-07
Last Posted Date
2025-04-15
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
2529
Registration Number
NCT03733080
Locations
🇺🇸

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery

Not Applicable
Recruiting
Conditions
Pituitary Neoplasm
Interventions
Other: ESC
First Posted Date
2018-09-19
Last Posted Date
2025-05-13
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
70
Registration Number
NCT03678389
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Clinical Laboratory Evaluation of Chronic Autonomic Failure

Active, not recruiting
Conditions
Autonomic Failure
Parkinson's Disease
Multiple System Atrophy
Interventions
Drug: 13N-Ammonia
Drug: 18F-DOPA
Drug: 11C-Methylreboxetine (11C-MRB)
Drug: 18F-Dopamine
First Posted Date
2018-08-28
Last Posted Date
2025-05-13
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
89
Registration Number
NCT03648905
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath